What to watch after talc-case law firm ouster and new AFib data
New York, Feb 7, 2026, 11:00 EST — The market has shut down for the day.
- Johnson & Johnson ended Friday’s session at $239.99, up 0.9%.
- Beasley Allen got tossed from New Jersey state talc litigation by an appeals court; a related motion at the federal level hasn’t been decided yet.
- J&J on this day shared initial 12-month pilot results for its investigational AFib device platform during a cardiology meeting
Johnson & Johnson (JNJ) stock climbed 0.9% to finish Friday at $239.99, landing close to its intraday peak, after a New Jersey appeals court ejected a major plaintiffs’ firm from part of the company’s talc lawsuits. Roughly 8.3 million shares traded hands. 1
The talc docket’s timing is…
